Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
Ginkgo Bioworks Acquires Modulus Cell Therapy Platform Assets
Details : Through the acquisition, Ginkgo will get access to the Modulus cell therapy platform assets, including their chimeric antigen receptor and switch receptor libraries for solid tumors, autoimmune, etc.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 04, 2024
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition